Home » ETF » IHE

IHE - iShares U.S. Pharmaceuticals ETF

Stock Price: $179.05 USD 1.25 (0.70%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Assets $355.40M
NAV $177.70
Expense Ratio 0.42%
PE Ratio 24.32
Beta (5Y) 0.89
Dividend (ttm) $2.18
Dividend Yield 1.23%
Ex-Dividend Date Mar 25, 2021
1-Year Return -
Trading Day April 16
Last Price $179.05
Previous Close $177.80
Change ($) 1.25
Change (%) 0.70%
Day's Open 178.89
Day's Range 178.06 - 179.28
Day's Volume 3,233
52-Week Range 144.25 - 187.42

Fund Description

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

Asset Class
Equity
Sector
Biotech
Region
North America
Inception Date
May 1, 2006
Exchange
NYSEARCA
Ticker Symbol
IHE
Index Tracked
Dow Jones U.S. Select Pharmaceuticals Index

Top 10 Holdings

77.50% of assets
NameSymbolWeight
Johnson & JohnsonJNJ23.29%
PfizerPFE17.60%
MerckMRK5.64%
ZoetisZTS4.73%
CatalentCTLT4.67%
Bristol-Myers SquibbBMY4.61%
Horizon TherapeuticsHZNP4.50%
ViatrisVTRS4.31%
Elanco Animal HealthELAN4.12%
Eli LillyLLY4.02%
View All Holdings

Dividends

Ex-DividendAmountPay Date
Mar 25, 2021$0.635Mar 31, 2021
Dec 14, 2020$0.526Dec 18, 2020
Sep 23, 2020$0.709Sep 29, 2020
Jun 15, 2020$0.314Jun 19, 2020
Mar 25, 2020$0.587Mar 31, 2020
Dec 16, 2019$0.515Dec 20, 2019
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...

Other tickers mentioned: BBH, FHLC, IEIH
4 days ago - ETF Trends

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

Other tickers mentioned: FDL, FTXH, IEIH
2 weeks ago - Zacks Investment Research

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

Other tickers mentioned: FTXH, PJP, PPH, XPH
2 months ago - Zacks Investment Research

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

Other tickers mentioned: FTXH, PJP, PPH, XPH
5 months ago - Zacks Investment Research

The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.

Other tickers mentioned: KURE, XPH
5 months ago - Investopedia

The coronavirus vaccine development effort has put the spotlight on the U.S. healthcare sector in recent months.

Other tickers mentioned: CNBS, GNOM, IHF, IHI, PJP, XHE
5 months ago - Zacks Investment Research

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

Other tickers mentioned: FTXH, PJP, PPH, XPH
8 months ago - Zacks Investment Research

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Other tickers mentioned: BBH, CNCR, FBT, IBB, IDNA, IHF, PBE ...
11 months ago - Zacks Investment Research

Strong results led to solid trading in pharma ETFs over the past week.

Other tickers mentioned: FTXH, PJP, PPH, XPH
1 year ago - Zacks Investment Research

Robust results led to solid trading in pharma ETFs in a month.

Other tickers mentioned: FTXH, PJP, PPH, XPH
1 year ago - Zacks Investment Research

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

Other tickers mentioned: IEIH, IYH, VHT, XLV
1 year ago - Zacks Investment Research

Healthcare stocks and sector-related exchange traded funds found support from a strong start to the earnings season after UnitedHealth Group (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ) provided a much...

Other tickers mentioned: IHF, XLV
1 year ago - ETF Trends

Despite robust results, pharma ETFs have been trending downward in a month.

Other tickers mentioned: FTXH, PJP, PPH, XPH
1 year ago - Zacks Investment Research

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

Other tickers mentioned: IEIH, IYH, VHT, XLV
1 year ago - Zacks Investment Research

Despite such robust results, pharma ETFs have been trending downward in a month.

Other tickers mentioned: FTXH, PJP, PPH, XPH
1 year ago - Zacks Investment Research